Literature DB >> 31886261

Integration of Gene Expression Profile Data of Human Epicardial Adipose Tissue from Coronary Artery Disease to Verification of Hub Genes and Pathways.

Weitie Wang1, Qing Liu2, Yong Wang1, Hulin Piao1, Bo Li1, Zhicheng Zhu1, Dan Li1, Tiance Wang1, Rihao Xu1, Kexiang Liu1.   

Abstract

BACKGROUND: This study aim to identify the core pathogenic genes and explore the potential molecular mechanisms of human coronary artery disease (CAD).
METHODOLOGY: Two gene profiles of epicardial adipose tissue from CAD patients including GSE 18612 and GSE 64554 were downloaded and integrated by R software packages. All the coexpression of deferentially expressed genes (DEGs) were picked out and analyzed by DAVID online bioinformatic tools. In addition, the DEGs were totally typed into protein-protein interaction (PPI) networks to get the interaction data among all coexpression genes. Pictures were drawn by cytoscape software with the PPI networks data. CytoHubba were used to predict the hub genes by degree analysis. Finally all the top 10 hub genes and prediction genes in Molecular complex detection were analyzed by Gene ontology and Kyoto encyclopedia of genes and genomes pathway analysis. qRT-PCR were used to identified all the 10 hub genes.
RESULTS: The top 10 hub genes calculated by the degree method were AKT1, MYC, EGFR, ACTB, CDC42, IGF1, FGF2, CXCR4, MMP2 and LYN, which relevant with the focal adhesion pathway. Module analysis revealed that the focal adhesion was also acted an important role in CAD, which was consistence with cytoHubba. All the top 10 hub genes were verified by qRT-PCR which presented that AKT1, EGFR, CDC42, FGF2, and MMP2 were significantly decreased in epicardial adipose tissue of CAD samples (p < 0.05) and MYC, ACTB, IGF1, CXCR4, and LYN were significantly increased (p < 0.05).
CONCLUSIONS: These candidate genes could be used as potential diagnostic biomarkers and therapeutic targets of CAD.
Copyright © 2019 Weitie Wang et al.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31886261      PMCID: PMC6900948          DOI: 10.1155/2019/8567306

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

Coronary artery disease (CAD) is a common cause of morbidity and mortality Worldwide [1]. Medical therapy and interventional or surgical techniques seem to save lots of patients with acute myocardial infarction in emergency phrase. However, long term outcomes remain unsatisfactory [2]. Thus further understanding of the etiology may provide potential diagnosis and therapeutic method for CAD. Recently, many reports present that epicardial adipose tissue (EAT) plays an important role in the progression of many disease by secretion various bioactive molecules [3]. In addition, finding also shows that the changing state of EAT will significantly affect the cardiac function and increase cardiovascular risk in human beings [4, 5]. CAD is a kind of coronary artery disease and most studies aim to research through the blood sample. However, EAT is found to have relevant with the heart because it is a type of visceral fat depot. The EAT widely distributes between the pericardium and myocardium which serves with metabolically activation [6]. Owing to its special location and close proximity to coronary vasculature, comparison of different express gene between EAT[7] and subcutaneous adipose tissue (SAT) may provide important information about the state of the coronary artery and maybe have potential for diagnosis and therapy for human CAD. mRNAs have been reported to participate in the regulation of pathophysiological conditions of cardiovascular disease (CVD) [8]. However, the existing results of mRNAs profiles of CAD can not identify the core pathogenic genes and the potential molecular mechanisms of human CAD [9-11]. Therefore, we downloaded the two mRNAs profiles data and screened out the co-expression differentially expressed genes (DEGs) between GSE 18612 and GSE 64554. After analyzing by biomathematical online tools and software, 10 hub genes were finally identified which could serve as new biomarkers and therapeutic targets for human CAD.

2. Materials and Methods

2.1. Microarray Analysis

This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Second Hospital of Jilin University. The two mRNA profiles were searched by CAD and EAT as well as human in gene expression omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo). All the data were provided from GPL96 platform. GSE 18612 contained 7 EAT from CAD patients and 6 SAT from noncoronary artery disease (NC) and there were 13 EAT from CAD patients and 10 SAT from NC patients in GSE 64554. All the data were analyzed with GEO2R online tool with two classifications including EAT and SAT.

2.2. Data Processing and Identifcation of DEGs

Downregulated and upregulated genes were selected in each profile with p < 0.05 and fold change >1.2 or < −1.2. R sofware including affy package [12]and limma package [13] were used to identify the final co-expression DEGs.

2.3. Gene Ontology and Pathway Enrichment Analyses

All DEGs and hub genes as well as predict genes in Molecular Complex Detection (MCODE) were analysis by DAVID (the Database for Annotation, Visualization, and Integrated Discovery) online bio-informatics database [14]. Gene ontology (GO) enrichment including cellular component (CC), biological processes (BP) and molecular function (MF) were acquired from DAVID. Pathway analysis of all DEGs was analysised by KEGG pathways tool. All the results were selected with gene count >2 and p < 0.05.

2.4. Integration of Protein-Protein Interaction (PPI) Network Analysis

The DEGs were totally typed into STRING (https://string-db.org/cgi/input.pl) database [15] to get PPI networks and the interaction data among all co-expression genes were picked with a significant confidence score >0.9. Then the interaction data were typed into the Cytoscape software [16] to structure a PPI network. Based on the above data, we used MCODE [17], a built-in APP in Cytoscape software, to analyze the interactive relationship of the DEGs encoding proteins and screen hub gene. The parameters of network scoring and cluster finding were set as follows: find clusters = in whole network, degree cutoff = 2, cluster finding = haircut, node score cutoff = 0.2, k-core = 2, and max depth = 100. The parameters of cytoHubba were set as follows: Hubba nodes = top 10 nodes ranked by degree, display options = check the first-stage nodes, display the shortest path and display the expanded sub network.

2.5. Quantitative Reverse Transcription-PCR (qRT-PCR) Validation and Statistical Analysis

qRT-PCR was used to verify the top 10 hug genes. PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa, Japan) was used to provide the process of RNA reverse-transcribed to cDNA. Primers were designed from Primer-BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast) and listed in Table 1. QuantStudio 7 Flex real-time PCR system (Applied Biosystems, Carlsbad, CA, USA) was used [18, 19] and samples were normalized to GAPDH. All the operations were according to the manufacturer's instructions. The relative expression levels of each gene were calculated using 2−ΔΔCt methods.
Table 1

The primers of the top 10 hub genes.

Gene nameForward primerReverse primer
AKT1AGCGACGTGGCTATTGTGAAGGCCATCATTCTTGAGGAGGAAGT
MYCGGCTCCTGGCAAAAGGTCACTGCGTAGTTGTGCTGATGT
EGFRAGGCACGAGTAACAAGCTCACATGAGGACATAACCAGCCACC
ACTBCATGTACGTTGCTATCCAGGCCTCCTTAATGTCACGCACGAT
CDC42CCATCGGAATATGTACCGACTGCTCAGCGGTCGTAATCTGTCA
IGF1GCTCTTCAGTTCGTGTGTGGAGCCTCCTTAGATCACAGCTCC
FGF2AGAAGAGCGACCCTCACATCACGGTTAGCACACACTCCTTTG
CXCR4ACTACACCGAGGAAATGGGCTCCCACAATGCCAGTTAAGAAGA
MMP2TACAGGATCATTGGCTACACACCGGTCACATCGCTCCAGACT
LYNGCTTTTGGCACCAGGAAATAGCTCATGTCGCTGATACAGGGAA
GAPDHCGGACCAATACGACCAAATCCGAGCCACATCGCTCAGACACC

3. Results

3.1. Identification of DEGs in the CAD and NC Groups

All of 20 EAT from CAD patients and 16 SAT from NC patients were analyzed with R software with a threshold setting at p < 0.05 and fold change >1.2. There were 2617 and 2192 DEGs in GSE 18612 and GSE 64554 mRNAs profiles, respectively. Finally, all 179 co-expression DEGs were selected through integrating analysis, which included 105 downregulated and 74 upregulated DEGs in EAT from CAD samples.

3.2. GO Functional Enrichment Analysis

All DEGs including downregulated and upregulated co-expression genes were typed into DAVID online tool respectively. The functions of GO analysis were divided into three classifications: BP, CC, and MF (Figure 1). As shown in Figure 1 and Table 2, in the biological processes group, the upregulated DEGs were mainly enriched in B cell receptor signaling pathway, cellular response to drug, adaptive immune response, inflammatory response, and negative regulation of protein phosphorylation, and the downregulated DEGs were mainly enriched in collagen catabolic process, cellular response to amino acid stimulus, endodermal cell differentiation and cell proliferation. In the cellular component group, the upregulated DEGs were mainly enriched in plasma membrane, cytosol, extracellular space, anchored component of membrane and extracellular region, and the downregulated DEGs were mainly enriched in extracellular matrix, extracellular exosome, protein complex, cytoplasm and cell-cell adherens junction. In the molecular function group, the upregulated DEGs were mainly enriched in identical protein binding, copper ion binding, protein complex binding, integrin binding and G-protein alpha-subunit binding, and the downregulated DEGs were mainly enriched in Rho GDP-dissociation inhibitor binding, ubiquitin protein ligase binding, cadherin binding involved in cell-cell adhesion, protein domain specific binding and lipoprotein lipase activity.
Figure 1

Gene Ontology analysis classified the differentially expressed genes into 3 groups:molecular function, biological process, and cellular component.

Table 2

The significantly enriched analysis of differentially expressed genes in coronary artery disease.

ExpressionCategoryTermDescriptionGene count P-value
UP-DEGsBPB cell receptor signaling pathwayGO:005085362.74E-06
BPAdaptive immune responseGO:000225063.55E-04
BPGO:inflammatory responseGO:000695489.15E-04
BPNegative regulation of protein phosphorylationGO:000193342.02E-03
BPLipopolysaccharide-mediated signaling pathwayGO:003166337.62E-03
CCPlasma membraneGO:0005886355.28E-06
CCCytosolGO:0005829267.67E-04
CCExtracellular spaceGO:0005615142.47E-03
CCAnchored component of membraneGO:003122541.05E-02
CCExtracellular regionGO:0005576132.56E-02
MFIdentical protein bindingGO:0042802102.44E-03
MFCopper ion bindingGO:000550732.02E-02
MFProtein complex bindingGO:003240344.68E-02
MFIntegrin bindingGO:000517836.36E-02
MFG-protein alpha-subunit bindingGO:000196527.18E-02
DOWN-DEGsBPCollagen catabolic processGO:003057463.55E-05
BPGO:cellular response to amino acid stimulusGO:007123051.60E-04
BPEndodermal cell differentiationGO:003598745.09E-04
BPCell proliferationGO:000828391.35E-03
BPReceptor-mediated endocytosisGO:000689864.68E-03
CCExtracellular matrixGO:0031012103.94E-05
CCExtracellular exosomeGO:0070062291.09E-03
CCProtein complexGO:004323472.71E-02
CCCytoplasmGO:0005737393.18E-02
CCCell-cell adherens junctionGO:000591363.39E-02
MFRho GDP-dissociation inhibitor bindingGO:005102222.21E-02
MFUbiquitin protein ligase bindingGO:003162562.21E-02
MFCadherin binding involved in cell-cell adhesionGO:009864162.30E-02
MFProtein domain specific bindingGO:001990452.89E-02
MFLipoprotein lipase activityGO:000446524.37E-02

3.3. Signaling Pathway Analysis

KEGG pathway analysis on DAVID online tool indicated that upregulated genes were mainly enriched in HIF-1 signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Salmonella infection and NF-kappa B signaling pathway. The downregulated genes were mainly enriched in Focal adhesion, Proteoglycans in cancer, PI3K-Akt signaling pathway, Ras signaling pathway, and Neurotrophin signaling pathway (Figure 2).
Figure 2

Kyoto encyclopedia of genes and genomes enrichment analysis of the pathways. The gradual color represents the P value; the size of the black spots represents the gene number.

3.4. PPI Network and Modular Analysis

STRING database presented a result with 178 nodes and 363 edges (Figure 3) after analysis of all the DEGs. The nodes and edges were put into the cytoscape software in order to acquire a PPI network. CytoHubba analysis section showed 10 hub genes, including AKT1, MYC, EGFR, ACTB, CDC42, IGF1, FGF2, CXCR4, MMP2, and LYN after degree calculation. In these 10 hub genes, AKT1 presented with the highest degree (degree = 38). The cytoscape plugin MCODE showed the top three modules with scores of 11.429, 3.333, and 3.000 (Figure 4). MCODE 1 contained 15 nodes including IL1B, AKT1, ANGPT2, MYC, LYN, FGF2, EGFR, TFRC, AR, ACTB, MMP2, IGF1, CDC42, CXCR4, and ANGPT1 with 80 edges. Then, all the 15 prediction genes in module 1 were analyzed by GO and KEGG analysis, which mainly aimed to Focal adhesion, MAPK signaling pathway, Salmonella infection, Adherens junction and Regulation of actin cytoskeleton. Module 2 was mainly associated with the Ubiquitin mediated proteolysis and Protein processing in endoplasmic reticulum. Module 3 was mainly associated with Protein digestion and absorption, ECM-receptor interaction, Focal adhesion and PI3K-Akt signaling pathway.
Figure 3

PPI network constructed with the differentially expressed genes. Blue nodes represent upregulated genes, purple nodes represent downregulated gene.

Figure 4

The top 10 hug gene analysis by cytoHubba (a). The gradual color represents the degree score. The most significance modules (b). Red nodes represent hug gene analysis by cytoHubba.

All the top 10 hub gene were verified by qRT-PCR which presented that AKT1, EGFR, CDC42, FGF2 and MMP2 were significantly decreased in EAT of CAD samples (p < 0.05) and MYC, ACTB, IGF1, CXCR4, and LYN were significantly increased (p < 0.05) (Figure 5). All validation data were consistent with the microarray data and analytical results in this study.
Figure 5

Validation of the mRNA microarray results by real-time qPCR. mRNA microarray results were verified by real-time qPCR between the CAD group (n = 10) and the control group (n = 10). All samples were normalized to the expression of GAPDH, and the relative expression levels of each gene were analyzed using the 2−Δ Δ Ctmethod. P < 0.05, P < 0.01.

4. Discussion

Adipose tissue has been thought to act as an endocrine organ to participate and regulate the inflammatory process of CVD through paracrine or endocrine pathway. Recent research points that EAT, an atypical fat depot surrounding the heart, plays essential roles in CAD not only highly metabolic paracrine and endocrine functions, but also by its blood supply from coronary circulation [20]. Therefore some changes of EAT may directly indicate the different state of the heart as they supplies from the same coronary blood. In the meantime, studies have points that metabolic function of EAT may participate the initiation and progression of atherosclerosis [21]. So researching on the EAT can be able to provide a promising therapeutic target for the treatment of CVD including atherosclerosis. With the fast development of sequencing technology, finding the changing genes between disease and normal tissue has become convenient. Up to now, there are many mRNAs profiles have been carried out and a lot of different genes have been detected between EAT and SAT from CAD patients [9-11]. mRNAs act as protein-coding genes, are believed to play an important role on modulating the metabolic function of adipose tissue and CAD. However, the initially change and the core pathogenic gene of CAD are not identified and the key pathogenesis of CAD has not been confirmed until now. As different expression profiles of CAD provided various results with each other, we integrated the mRNAs profiles and analysised the co-expression DEGs. In this study, 105 downregulated DEGs and 74 upregulated DEGs were identified after integrating profile datasets. Similar to other studies [22, 23], these DEGs were dealt with GO and pathway analysis and a lot of KEGG pathways were found. However, the hub gene in CAD and the most relevant pathway and mechanism of CAD could not be identified. Therefore, we used more bioinformation tools such as PPI Network online tool, cytoscape analysis with cytoHubba and MCODE analysis for further analyses. The cytoHubba analysis showed that the top ten hub genes were AKT1, MYC, EGFR, ACTB, CDC42, IGF1, FGF2, CXCR4, MMP2, and LYN. DAVID on line analysis tool predicted that these genes were highly relevant with the focal adhesion pathway in CAD. In addition, the MCODE provided another analysis of these DEGs. The top 1 MCODE contained 15 nodes including IL1B, AKT1, ANGPT2, MYC, LYN, FGF2, EGFR, TFRC, AR, ACTB, MMP2, IGF1, CDC42, CXCR4, ANGPT1 and 80 edges. These 15 nodes also indicated that Focal adhesion might act as the most relevant pathway after analysis by DAVID. Even better, the predicted genes in top 1 MCODE also contained all the top 10 hug genes. Therefore, we aimed to analyze the hub gene AKT1 and the Focal adhesion in CAD. Akt kinase has been identified as one of the member of AGC kinases (AMP/GMP kinase and PKC subfamily of proteins), which is reported to play an important role in cell proliferation, migration and growth [24]. Although Akt1, Akt2, and Akt3 are the 3 isoforms of Akt, they play different functions in various cell environment. Recent study shows that Akt acts critical roles in the CVD including atherosclerosis [25]. The reduction of endothelial cell migration was found when Akt phosphorylation influenced by oxidized low density lipoprotein (LDL) [26]. In addition, inhibition of Akt in macrophages was also presented with reducing atherosclerosis [27]through decreasing in proinflammation and immune cell migration. Recent study also presented that inhibition of vascular endothelial growth factor (VEGF) through inducing Akt phosphorylation pathway might protect arteries from atherosclerosis through changing the peroxisome proliferator-activated receptors (PPARs). Therefore, the toppest hub gene Akt was believed to serve as a hub gene in the initial and progressive pathological in atherosclerosis. Akt has been reported to activate or over expression with focal adhesion kinase (FAK) pathway signal. Reports show that interaction between FAK and Akt1 is found in many cancers. This interaction is always needed for subsequent FAK autophosphorylation, activation, and translocation to the focal adhesion complex (FAC) [28]. FAK was reported to participate in regulating cell adhesion, mobility and proliferation during many cell process. The focal adhesion signaling had provided insight into the role of FAK in cardiomyocyte signal transduction and had been reported to contribute to myocardial remodeling and the progression to heart failure [29]. In addition, FAK was also reported taking part in regulating the function of endothelial barrier [30]. Low expression of FAK in endothelial cells would result in formation of a tighter endothelial monolayer through raising cell attachment and connection. In addition, disruption of FAC would also lead to Ado/HC-induced endothelial apoptosis [31] and lipid would deposition following endothelial cell damage. Study also pointed that FAK played a role in reduction of lipopolysaccharide-induced inflammation injury through inactivation of the Wnt and NF-kappaB pathways [32] and inflammation injury was also an important factor during CAD. So focal adhesion signaling might act an important role in vascular endothelial dysfunction and pro-inflammatory reactions, and might be a core change during CAD. In summary, by integration of different high-throughput sequencing profiles and data processing as well as hub genes, these genes may have the potential to be used as drug targets and diagnostic markers of CAD. The focal adhesion maybe the key pathway in CAD. However, there are still some limitations: further experimental studies with larger sample sizes are needed to confirm the role of the focal adhesion pathway in CAD.
  32 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  affy--analysis of Affymetrix GeneChip data at the probe level.

Authors:  Laurent Gautier; Leslie Cope; Benjamin M Bolstad; Rafael A Irizarry
Journal:  Bioinformatics       Date:  2004-02-12       Impact factor: 6.937

3.  The mRNA Expression and Circulating Levels of Visfatin and Their Correlation with Coronary Artery Disease Severity and 25-Hydroxyvitamin D.

Authors:  R Fadaei; E Parvaz; S Emamgholipour; N Moradi; A Vatannejad; M Najafi; M Doosti
Journal:  Horm Metab Res       Date:  2015-10-14       Impact factor: 2.936

Review 4.  Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features.

Authors:  Gianluca Iacobellis; Antonio C Bianco
Journal:  Trends Endocrinol Metab       Date:  2011-08-16       Impact factor: 12.015

5.  Loss of focal adhesion kinase enhances endothelial barrier function and increases focal adhesions.

Authors:  Kimberly M Arnold; Zoe M Goeckeler; Robert B Wysolmerski
Journal:  Microcirculation       Date:  2013-10       Impact factor: 2.628

6.  Integrative miRNA and whole-genome analyses of epicardial adipose tissue in patients with coronary atherosclerosis.

Authors:  Michele Vacca; Marco Di Eusanio; Marica Cariello; Giusi Graziano; Simona D'Amore; Francesco Dimitri Petridis; Andria D'orazio; Lorena Salvatore; Antonio Tamburro; Gianluca Folesani; David Rutigliano; Fabio Pellegrini; Carlo Sabbà; Giuseppe Palasciano; Roberto Di Bartolomeo; Antonio Moschetta
Journal:  Cardiovasc Res       Date:  2015-12-08       Impact factor: 10.787

7.  Akt1 promotes focal adhesion disassembly and cell motility through phosphorylation of FAK in growth factor-stimulated cells.

Authors:  Maiko Higuchi; Rina Kihara; Tomohiko Okazaki; Ichiro Aoki; Shiro Suetsugu; Yukiko Gotoh
Journal:  J Cell Sci       Date:  2012-12-21       Impact factor: 5.285

Review 8.  Inflammation-regulated mRNA stability and the progression of vascular inflammatory diseases.

Authors:  Allison B Herman; Michael V Autieri
Journal:  Clin Sci (Lond)       Date:  2017-11-06       Impact factor: 6.124

9.  Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.

Authors:  Qingwei Ji; Jianwei Zhang; Yu Du; Enjun Zhu; Zhijian Wang; Bin Que; Huangtai Miao; Shutian Shi; Xiuchuan Qin; Yingxin Zhao; Yujie Zhou; Fangjun Huang; Shaoping Nie
Journal:  Cardiovasc Diabetol       Date:  2017-10-16       Impact factor: 9.951

10.  Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice.

Authors:  Vladimir R Babaev; Katie E Hebron; Carrie B Wiese; Cynthia L Toth; Lei Ding; Youmin Zhang; James M May; Sergio Fazio; Kasey C Vickers; MacRae F Linton
Journal:  J Lipid Res       Date:  2014-09-19       Impact factor: 5.922

View more
  5 in total

1.  Evaluation of Exosomal miRNA in Blood as a Potential Diagnostic Biomarker for Human Non-Small Cell Lung Cancer.

Authors:  Zhenan Xu; Zhenxing Wang; Hongbin Sun; Hua Xin
Journal:  Med Sci Monit       Date:  2020-05-23

2.  lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing Hypertrophic Cardiomyopathy.

Authors:  Wei Feng; Shuo Han
Journal:  Oxid Med Cell Longev       Date:  2022-03-31       Impact factor: 6.543

3.  The association between ACTB methylation in peripheral blood and coronary heart disease in a case-control study.

Authors:  Jialie Jin; Chao Zhu; Jinxin Wang; Xiaojing Zhao; Rongxi Yang
Journal:  Front Cardiovasc Med       Date:  2022-08-18

Review 4.  A description of the relationship in healthy longevity and aging-related disease: from gene to protein.

Authors:  Xiaolin Ni; Zhaoping Wang; Danni Gao; Huiping Yuan; Liang Sun; Xiaoquan Zhu; Qi Zhou; Ze Yang
Journal:  Immun Ageing       Date:  2021-06-25       Impact factor: 6.400

5.  Multiple Bioinformatics Analyses of Integrated Gene Expression Profiling Data and Verification of Hub Genes Associated with Diabetic Retinopathy.

Authors:  Jiaxin You; Shounan Qi; Yang Du; Chenguang Wang; Guanfang Su
Journal:  Med Sci Monit       Date:  2020-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.